blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2065052

EP2065052 - Anti-IgE vaccines [Right-click to bookmark this link]
StatusThe application has been refused
Status updated on  21.02.2014
Database last updated on 05.10.2024
Most recent event   Tooltip21.02.2014Refusal of applicationpublished on 26.03.2014  [2014/13]
Applicant(s)For all designated states
Zoetis P LLC
100 Campus Drive
Florham Park, New Jersey 07932 / US
[N/P]
Former [2013/28]For all designated states
Zoetis P LLC
100 Campus Drive
Florham Park, New Jersey 07932 / US
Former [2013/07]For all designated states
PAH USA 15 LLC
235 East 42nd Street
New York, NY 10017-5755 / US
Former [2009/23]For all designated states
Pfizer Products Inc.
Eastern Point Road
Groton, CT 06340 / US
Inventor(s)01 / Morsey, Mohamad Ali
Pfizer Global Research and Development Eastern Point Road
Groton, CT 06340 / US
02 / Sheppard, Michael George
Pfizer Global Research and Development Eastern Point Road
Groton, CT 06340 / US
03 / Wheeler, David Walter
Pfizer Global Research and Development Eastern Point Road
Groton, CT 06340 / US
 [2009/23]
Representative(s)Mannion, Sally Kim, et al
Zoetis UK Limited
Walton Oaks
Dorking Road
Tadworth
Surrey KT20 7NS / GB
[2013/34]
Former [2013/17]Mannion, Sally Kim
Pfizer Animal Health
Walton Oaks
Dorking Road
Tadworth, Surrey KT20 7NS / GB
Former [2012/33]Pfizer
European Patent Department
23-25 avenue du Docteur Lannelongue
75668 Paris Cedex 14 / FR
Former [2009/23]Ricol, David Gerard, et al
Pfizer Limited European Patent Department Ramsgate Road
Sandwich, Kent CT13 9NJ / GB
Application number, filing date09154655.624.08.2001
[2009/23]
Priority number, dateUS20000228989P30.08.2000         Original published format: US 228989 P
[2009/23]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP2065052
Date:03.06.2009
Language:EN
[2009/23]
Type: A3 Search report 
No.:EP2065052
Date:19.08.2009
[2009/34]
Search report(s)(Supplementary) European search report - dispatched on:EP22.07.2009
ClassificationIPC:A61K39/385, C07K16/00, A61K39/395
[2009/23]
CPC:
A61K39/0008 (EP,US); A61P1/00 (EP); A61P1/04 (EP);
A61P11/02 (EP); A61P11/06 (EP); A61P13/12 (EP);
A61P27/02 (EP); A61P27/14 (EP); A61P37/00 (EP);
A61P37/02 (EP); A61P37/08 (EP); C07K16/00 (EP,US);
A61K2039/505 (EP,US); A61K39/00 (EP,US); C07K2317/52 (EP,US);
C07K2319/00 (EP,US); Y10S424/805 (EP,US); Y10S435/81 (EP,US);
Y10S530/868 (EP,US) (-)
C-Set:
A61K39/0008, A61K2300/00 (EP,US)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2009/23]
TitleGerman:Anti-IgE Vakzine[2009/23]
English:Anti-IgE vaccines[2009/23]
French:Anti-IgE vaccins[2009/23]
Examination procedure19.02.2010Examination requested  [2010/13]
18.03.2010Despatch of a communication from the examining division (Time limit: M06)
27.09.2010Reply to a communication from the examining division
18.07.2011Despatch of a communication from the examining division (Time limit: M06)
06.03.2012Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
20.04.2012Reply to a communication from the examining division
02.10.2013Cancellation of oral proceeding that was planned for 04.12.2013
05.11.2013Despatch of communication that the application is refused, reason: substantive examination [2014/13]
15.11.2013Application refused, date of legal effect [2014/13]
04.12.2013Date of oral proceedings (cancelled)
Parent application(s)   TooltipEP01307247.5  / EP1195161
Divisional application(s)EP10183753.2  / EP2361635
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20010307247) is  10.11.2006
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
20.04.2012Request for further processing filed
20.04.2012Full payment received (date of receipt of payment)
Request granted
07.05.2012Decision despatched
Fees paidRenewal fee
09.07.2009Renewal fee patent year 03
09.07.2009Renewal fee patent year 04
09.07.2009Renewal fee patent year 05
09.07.2009Renewal fee patent year 06
09.07.2009Renewal fee patent year 07
09.07.2009Renewal fee patent year 08
07.08.2009Renewal fee patent year 09
31.08.2010Renewal fee patent year 10
31.08.2011Renewal fee patent year 11
31.08.2012Renewal fee patent year 12
07.08.2013Renewal fee patent year 13
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]WO8800204  (RESEARCH CORP [GB]);
 [X]WO9305810  (HELLMAN LARS T [SE]);
 [X]WO9824808  (US HEALTH [US], et al);
 [X]US5965709  (PRESTA LEONARD G [US], et al);
 [X]WO9967293  (UNITED BIOMEDICAL INC [US], et al);
 [X]WO0023477  (UNIV SHEFFIELD [GB], et al);
by applicantEP0263655
 US4980286
 WO9206180
 WO9220316
 WO9222635
 WO9314188
 WO9320221
 WO9408598
 WO9412649
 US5436146
 US5601821
 US5653980
 WO9731948
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.